Literature DB >> 8040312

Anti-nucleosome antibodies complexed to nucleosomal antigens show anti-DNA reactivity and bind to rat glomerular basement membrane in vivo.

C Kramers1, M N Hylkema, M C van Bruggen, R van de Lagemaat, H B Dijkman, K J Assmann, R J Smeenk, J H Berden.   

Abstract

Histones can mediate the binding of DNA and anti-DNA to the glomerular basement membrane (GBM). In ELISA histone/DNA/anti-DNA complexes are able to bind to heparan sulfate (HS), an intrinsic constituent of the GBM. We questioned whether histone containing immune complexes are able to bind to the GBM, and if so, whether the ligand in the GBM is HS. Monoclonal antibodies (mAbs) complexed to nucleosomal antigens and noncomplexed mAbs were isolated from culture supernatants of four IgG anti-nuclear mAbs. All noncomplexed mAbs showed strong anti-nucleosome reactivity in ELISA. One of them showed in addition anti-DNA reactivity in noncomplexed form. The other three mAbs only showed anti-DNA reactivity when they were complexed to nucleosomal antigens. After renal perfusion a fine granular binding of complexed mAbs to the glomerular capillary wall and activation of complement was observed in immunofluorescence, whereas noncomplexed mAbs did not bind. Immuno-electron microscopy showed binding of complexes to the whole width of the GBM. When HS in the GBM was removed by renal heparinase perfusion the binding of complexed mAb decreased, but did not disappear completely. We conclude that anti-nucleosome mAbs, which do not bind DNA, become DNA reactive once complexed to nucleosomal antigens. These complexed mAbs can bind to the GBM. The binding ligand in the GBM is partly, but not solely, HS. Binding to the GBM of immune complexes containing nucleosomal material might be an important event in the pathogenesis of lupus nephritis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8040312      PMCID: PMC296132          DOI: 10.1172/JCI117371

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  38 in total

1.  Anti-dsDNA and complement profiles as prognostic guides in systemic lupus erythematosus.

Authors:  A J Swaak; L A Aarden; L W Statius van Eps; T E Feltkamp
Journal:  Arthritis Rheum       Date:  1979-03

2.  Systemic lupus erythematosus: prototype of immune complex nephritis in man.

Authors:  D Koffler; V Agnello; R Thoburn; H G Kunkel
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

3.  Clinical evaluation of a modified ELISA, using photobiotinylated DNA, for the detection of anti-DNA antibodies.

Authors:  M N Hylkema; H Huygen; C Kramers; T J vd Wal; J de Jong; M C van Bruggen; A J Swaak; J H Berden; R J Smeenk
Journal:  J Immunol Methods       Date:  1994-03-29       Impact factor: 2.303

Review 4.  Autoantibodies to nuclear antigens (ANA): their immunobiology and medicine.

Authors:  E M Tan
Journal:  Adv Immunol       Date:  1982       Impact factor: 3.543

5.  Avidity of anti-DNA antibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus. Association of high avidity antinative DNA antibody with glomerulonephritis.

Authors:  J B Winfield; I Faiferman; D Koffler
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

6.  Murine monoclonal anti-DNA antibodies bind directly to glomerular antigens and form immune deposits.

Authors:  M P Madaio; J Carlson; J Cataldo; A Ucci; P Migliorini; O Pankewycz
Journal:  J Immunol       Date:  1987-05-01       Impact factor: 5.422

7.  The kinetics of clearance of human antibody/dsDNA immune complexes from rabbit circulation. Effects of dsDNA size, rheumatoid factor, and reduction and alkylation of the antibodies.

Authors:  R P Taylor; G Kujala; J C Edberg; P Foreman; J S Davis; E Wright
Journal:  J Immunol       Date:  1986-05-15       Impact factor: 5.422

8.  A role for histones and ubiquitin in lupus nephritis?

Authors:  F Stöckl; S Muller; S Batsford; T Schmiedeke; R Waldherr; K Andrassy; Y Sugisaki; K Nakabayashi; T Nagasawa; B Rodriguez-Iturbe
Journal:  Clin Nephrol       Date:  1994-01       Impact factor: 0.975

9.  A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures.

Authors:  R W Farndale; C A Sayers; A J Barrett
Journal:  Connect Tissue Res       Date:  1982       Impact factor: 3.417

10.  Clearance of circulating DNA-anti-DNA immune complexes in mice.

Authors:  W Emlen; M Mannik
Journal:  J Exp Med       Date:  1982-04-01       Impact factor: 14.307

View more
  59 in total

1.  Lupus autoantibodies 101: one size does not fit all; however, specificity influences pathogenicity.

Authors:  M P Madaio
Journal:  Clin Exp Immunol       Date:  2003-03       Impact factor: 4.330

2.  Glomerular Autoimmune Multicomponents of Human Lupus Nephritis In Vivo (2): Planted Antigens.

Authors:  Maurizio Bruschi; Maricla Galetti; Renato Alberto Sinico; Gabriella Moroni; Alice Bonanni; Antonella Radice; Angela Tincani; Federico Pratesi; Paola Migliorini; Corrado Murtas; Franco Franceschini; Barbara Trezzi; Francesca Brunini; Rita Gatti; Regina Tardanico; Giancarlo Barbano; Giorgio Piaggio; Piergiorgio Messa; Pietro Ravani; Francesco Scolari; Giovanni Candiano; Alberto Martini; Landino Allegri; Gian Marco Ghiggeri
Journal:  J Am Soc Nephrol       Date:  2014-11-14       Impact factor: 10.121

3.  Anti-chromatin antibodies in systemic lupus erythematosus: a useful marker for lupus nephropathy.

Authors:  R Cervera; O Viñas; M Ramos-Casals; J Font; M García-Carrasco; A Sisó; F Ramírez; Y Machuca; J Vives; M Ingelmo; R W Burlingame
Journal:  Ann Rheum Dis       Date:  2003-05       Impact factor: 19.103

Review 4.  Neutrophils in the pathogenesis and manifestations of SLE.

Authors:  Mariana J Kaplan
Journal:  Nat Rev Rheumatol       Date:  2011-09-27       Impact factor: 20.543

5.  Targeted tumor necrosis factor receptor I preligand assembly domain improves skin lesions in MRL/lpr mice.

Authors:  Guo-Min Deng; Lena Liu; George C Tsokos
Journal:  Arthritis Rheum       Date:  2010-08

6.  Nephritogenic lupus antibodies recognize glomerular basement membrane-associated chromatin fragments released from apoptotic intraglomerular cells.

Authors:  Manar Kalaaji; Elin Mortensen; Leif Jørgensen; Randi Olsen; Ole Petter Rekvig
Journal:  Am J Pathol       Date:  2006-06       Impact factor: 4.307

7.  The binding of lupus-derived autoantibodies to the C-terminal peptide (83-119) of the major SmD1 autoantigen can be mediated by double-stranded DNA and nucleosomes.

Authors:  J W Dieker; C C Van Bavel; G Riemekasten; J H Berden; J van der Vlag
Journal:  Ann Rheum Dis       Date:  2006-03-15       Impact factor: 19.103

Review 8.  T cells of lupus and molecular targets for immunotherapy.

Authors:  S K Datta; A Kaliyaperumal; A Desai-Mehta
Journal:  J Clin Immunol       Date:  1997-01       Impact factor: 8.317

9.  Pharmacodynamics of recombinant human DNase I in serum.

Authors:  W S Prince; D L Baker; A H Dodge; A E Ahmed; R W Chestnut; D V Sinicropi
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

Review 10.  The Role of Anti-DNA Antibodies in the Development of Lupus Nephritis: A Complementary, or Alternative, Viewpoint?

Authors:  Beatrice Goilav; Chaim Putterman
Journal:  Semin Nephrol       Date:  2015-09       Impact factor: 5.299

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.